Vigil Neuroscience, Inc.
VIGL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $452 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $124 | $226 | $114 |
| Gross Profit | $0 | -$124 | $226 | -$114 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $17,410 | $16,511 | $18,668 | $13,772 |
| G&A Expenses | $10,081 | $6,958 | $6,446 | $6,904 |
| SG&A Expenses | $10,081 | $6,958 | $6,446 | $6,904 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $27,491 | $23,469 | $25,114 | $20,676 |
| Operating Income | -$27,491 | -$23,469 | -$25,114 | -$20,676 |
| % Margin | – | – | -5,556.2% | – |
| Other Income/Exp. Net | $828 | $1,056 | $1,283 | $1,418 |
| Pre-Tax Income | -$26,663 | -$22,413 | -$23,831 | -$19,258 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$26,663 | -$22,413 | -$23,831 | -$19,258 |
| % Margin | – | – | -5,272.3% | – |
| EPS | -0.56 | -0.49 | -0.57 | -0.47 |
| % Growth | -14.3% | 14% | -21.3% | – |
| EPS Diluted | -0.56 | -0.49 | -0.57 | -0.47 |
| Weighted Avg Shares Out | 47,620 | 46,068 | 41,657 | 40,578 |
| Weighted Avg Shares Out Dil | 47,620 | 46,068 | 41,657 | 40,578 |
| Supplemental Information | – | – | – | – |
| Interest Income | $836 | $1,060 | $1,277 | $1,410 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $129 | $124 | $113 | $114 |
| EBITDA | -$27,362 | -$22,289 | -$25,001 | -$20,562 |
| % Margin | – | – | -5,531.2% | – |